R
70
-3
T
48
3
XEL
67
2
GS
72
4
ADP
65
-3
SWK
50
-5
M
31
-3
SLG
57
-3
EMR
71
-3
STI
45
26
BXP
49
-3
THC
60
-5
HRL
35
-3
AMGN
42
-4
CINF
53
3
FAST
57
-3
AEP
54
6
DHI
44
-3
CMA
61
-3
PAYX
48
-6
R
70
-3
T
48
3
XEL
67
2
GS
72
4
ADP
65
-3
SWK
50
-5
M
31
-3
SLG
57
-3
EMR
71
-3
STI
45
26
BXP
49
-3
THC
60
-5
HRL
35
-3
AMGN
42
-4
CINF
53
3
FAST
57
-3
AEP
54
6
DHI
44
-3
CMA
61
-3
PAYX
48
-6
Financhill
Back

Tekla World Healthcare Fund Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
7

THW
Tekla World Healthcare Fund

Last Price:
11.76
Seasonality Move:
0.66%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.56
Seasonality Move:
17.03%
Sell
7
Tekla World Healthcare Fund (THW) is a Sell

Is Tekla World Healthcare Fund a Buy, Sell or Hold?

  • The current Tekla World Healthcare Fund [THW] share price is $11.54. The Score for THW is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
  • THW is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

THW Stock Price Chart

What is Tekla World Healthcare Fund's stock price today?

  • The Tekla World Healthcare Fund share price today is $11.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and THW is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

THW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 17.63 Sell
Chaikin Money Flow: -173863 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.14 - 12.9) Sell
Bollinger Bands (100): (12.62 - 13.32) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

THW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.13 Sell
20-day SMA: 12.4 Sell
50-day SMA: 12.85 Sell
200-day SMA: 12.89 Sell
8-day EMA: 12.06 Sell
20-day EMA: 12.35 Sell
50-day EMA: 12.68 Sell
200-day EMA: 12.85 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Tekla World Healthcare Fund Earnings Growth & THW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Tekla World Healthcare Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):